No abstract available
MeSH terms
-
Antiviral Agents / therapeutic use*
-
Combined Modality Therapy
-
Drug Therapy, Combination
-
Filtration
-
Hepacivirus / isolation & purification
-
Hepatitis C, Chronic / immunology
-
Hepatitis C, Chronic / therapy*
-
Hepatitis C, Chronic / virology
-
Humans
-
Interferon alpha-2
-
Interferon-alpha / administration & dosage
-
Interferon-alpha / therapeutic use
-
Plasmapheresis / methods*
-
Polyethylene Glycols / administration & dosage
-
Polyethylene Glycols / therapeutic use
-
Recombinant Proteins / administration & dosage
-
Recombinant Proteins / therapeutic use
-
Ribavirin / administration & dosage
-
Ribavirin / therapeutic use
-
Treatment Outcome
Substances
-
Antiviral Agents
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins
-
Polyethylene Glycols
-
Ribavirin
-
peginterferon alfa-2b
-
peginterferon alfa-2a